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Abstract. a301 (VLA-3), a member of the integrin
family of cell adhesion receptors, may function as a
receptor for fibronectin, laminin, and collagen . A par-
tial cDNA clone (2 .4 kb) for the human a3 subunit
was selected from an endothelial cell Agtll cDNA li-
brary by specific antibody screening. Several overlap-
ping cDNA clones were subsequently obtained, of a
total length of 4.6 kb from various cDNA libraries .
The reconstructed a3 cDNA was expressed on the sur-
face of chinese hamster ovary cells as detected by an
a3-specific mAb after transfection, suggesting that the
cDNA is authentic. Within this sequence was an open
reading frame, encoding for 1,051 amino acids, includ-
ing a signal peptide of 32 residues, a long extracellu-
lar domain (959 residues), a transmembrane domain
(28 residues), and a short cytoplasmic segment (32
CIA (VLA-3), a cell surface heterodimer composed of a3
and 01 subunits, is an integrin (1, 6, 19, 23, 27) that has
been implicated as a receptor for collagen, laminin, and
fibronectin (13, 17, 18, 49, 54). The role of a3a1 has been
somewhat difficult to assess, partly because its adhesive
functions are often obscured by other collagen, laminin, and
fibronectin receptors such as a201, a6,Q1 and a501 (13). The
binding of a3a1 to its different ligands appears to be accom-
plished by multiple binding mechanisms. For example, U3,Q1
binding to fibronectin differs substantially from binding to
collagen and laminin with respect to both the divalent cation
requirements and the influence of RGD peptides (13). In ad-
dition to being a receptor for extracellular matrix ligands,
aA could possibly also bind to cell surface ligands, as in-
ferred from x301 localization to cell-cell contact sites (7,
31, 35).
In normal tissue, COO, expression is limited to a few cell
types, including kidney glomeruli, and the basal cells of
epidermis and other epithelia (7, 16, 34, 35). In contrast,
nearly all cultured cell lines express a3N, except for lym-
phoid cells (16). Underscoring the likely importance of
C01-mediated cell adhesion, its expression levels have been
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residues). Overall, the a3 amino acid sequence was
25-37% similar to the other integrin a subunits that
are cleaved, with most similarity to the a6 sequence
(37%), and less similarity to those a subunits that
have I domains (15-20%, excluding the I domain se-
quence itself). Features most like those in other a
subunits are (a) the positions of 18/19 cysteine resi-
dues, (b) three potential metal binding domains of the
general structure DX(D/N)X(D/N)GXXD, and (c) the
predicted transmembrane domain. The mass of a3 cal-
culated from its amino acid sequence is 113,505. The
human a3 sequence was 89% identical to hamster ga-
lactoprotein b3, and 70% similar to the chicken CSAT
antigen band 2 protein partial sequence, suggesting that
these two polypeptides are homologues of human a3 "
noted to vary on different cell types and with different growth
conditions. For example, a301 levels diminished in re-
sponse to TGF,Q in one case (22), but were increased in other
examples (21). Also, a,81 can be induced by attachment of
some cultured cells to extracellular matrix (40) while a3a1
levels decrease upon shifting of fibroblasts from exponential
growth to quiescence (14) .
On rat (37) and human (34) transformed cells, x3/31 levels
were elevated, suggesting that a3(31 could possibly contrib-
ute to tumorigenicity and/or invasiveness. However, in sev-
eral other studies, «3a1 levels were either unchanged or de-
creased on malignant cells (11, 35, 36), emphasizing that
regulation of a301 expression on cancer cells is complex .
In this paper we have cloned, sequenced, and expressed
in eukaryotic cells the cDNA for the 013 subunit of C01. We
have found that a3 resembles other integrin a subunits in
having a signal peptide, a long extracellular domain (959
residues) and a putative transmembrane domain and a short
cytoplasmic segment (32 residues). The extracellular do-
main includes 18 conserved cysteine residues and three
metal binding domains of the general structure DX(D/N)-
X(D/N)GXXD. The 0e3 subunit amino acid sequence was
257Figure 1 . Immunological crossreactivity between purified 013 and
01 3 fusion proteins . O-Galactosidase fusion proteins were produced
from clones 3.22 (lane a), 3.24 (lane b), 3.25 (lane c), and 3.26
(lane d) that had been immunoselected using anti-01 3 antiserum .
NP-40-insoluble material from these fusion protein preparations
and from uninfected Y1089E. coli (lane e) was analyzed by SDS-
PAGE and stained for protein using Coomassie blue as shown in
A . After blotting of these proteins onto nitrocellulose, immuno-
staining with enriched anti-013 antibodies (11500-111,000 final dilu-
tion) was carried out (B) . For C, purified fusion protein from clone
3.22 was used to prepare fusion protein-enriched antiserum as de-
scribed in Materials and Methods, and this antibody stained both
the fusion protein from clone 3.22 and purified 013 protein . The
comigration of the fusion protein and 01 3 protein at -150,000 M,
is fortuitous.
most similar to the integrin ab subunit (37% identity), and
had 25-30% identity to other integrin a subunits . Also, the
013 subunit was 89% identical to hamster galactoprotein b3,
a protein reportedly upregulated in oncogene-transformed
fibroblasts (52), and was 70% similar to the avianCSAT an-
tigen band 2 partial amino acid sequence (43), suggesting
that they are homologues of human 013 subunit .
MaterialsandMethods
Purification ofC1301 andPreparation of
CO-specificAntiserum
The anti-013 mAb J143 (16) was coupled to CNBr-Sepharose (Pharmacia
Fine Chemicals, f'iscataway, NJ) accordingto themanufacturer's instructions
and then used for immunoaffinity purification of 0301 heterodimer from
placental cell extracts as previously described (49) . The 013 and 01 subunits
from purified 030 1 complex (containing 30-50 pg of (X3 subunit) were then
separated using preparative 5% SDS-PAGE and transferred to nitrocellu-
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lose. After localization of the 013 band relative to 1251-labeled 013 subunit by
autoradiography, that band was cut out and solubilized in the minimum
amount ofDMSO. After multiple (5-10 l'g) injections ofpurified 013 mate-
rial in Freund's adjuvant, rabbit anti -013 antiserum was obtained .
To obtain antibodies enriched for anti-013 binding activity, purified 0 301
complex (isolated using the J143 mAb column as describedabove) was used
to prepare an immunoaffinity column . First, purified 0301 was denatured
by boiling for 5 min in the presence of 1% SDS, and coupled to CNBr-
Sepharose according to the manufacturer's instructions (exceptthat coupling
buffer included 0.1% SDS) . Then crude rabbit anti -013 serum was passed
over the 01301-Sepharose affinity column, and the column was washed suc-
cessively with 3 column vol each of PBST' (0.14M NaCl, 10 mM sodium
phosphate, 0.2% Tween20), 0.2M KSCN, andthen PBST again. Forelution
of anti-013 antibodies, 3 .5 M KSCN was added, and then the eluate (with
0.1% hemoglobin carrier protein) was desalted using a Sephadex G-25
column equilibrated with PBST.
Several putative 013 cDNA clones (isolated as described below) were
used to produce 0-galactosidase fusion proteins in lysogenic Y1089 Esche-
richia coli as described (26) . The insoluble fusion proteins from these
clones were purified by repeated washing of the insoluble pellet with 1%
NP-40, 0.14 M NaCl and 10 mM sodium phosphate, pH 7.4 . The NP-40-
insoluble fusion protein was further separated by SDS-PAGE and the
stained band was cut out from the gel, electroeluted, coupled to Sepharose
and thenused to positively selectanti-fusionprotein antibodies from crude
anti 013 serum .
Isolation of U 3 cDNA
An oligo dT primed Xgtl l expressioncDNA library, made from endothelial
cells wasthe kind gift ofDr. Tucker Collins (Brigham andWomen's Hospi-
tal, Boston, MA) . That library was screened using affinity-purified 013 anti-
bodies according to the method of Young and Davis (55) . Positive clones
from phage screening were plaque purified and the phage DNA was pre-
pared by the plate lysate method (33) . The insert cDNA was cut out from
the phage DNA by EcoRI digestion and subcloned into either pGEM-3
(Promega Biotec, Madison, WI) or Bluescript KS+ plasmid (Stratagene
Corp., La Jolla, CA) as previously described (46, 50) .
The initially selected clone 3.24 included only the 3' noncoding region
and -100 COOH-terminal amino acid residues . Using 32P-labeled 3.24
cDNA as a probe, additional clones (3.122, 3.285) were selected from a
XgtlI cDNA library made from the hepatocarcinoma cell line Hep G2 ; a
kind gift from Drs . M . Muckler (Massachusetts Institute of Technology,
Boston) and M . Krangel (Dana Farber Cancer Institute, Boston) . Using
32P-labeled 3.122 cDNA as probe, further screening was carried out to
finally select clones (3.410 and 3.520) from a different human endothelial
cell Agtl l cDNA library (from Dr. J. E . Sadler, Washington University, St .
Louis, MO) . The insert cDNA was cut out from the phage DNA by Sall
digestion in this case . Clone 3.410 includedthe translation initiation site and
5' noncoding region of the 013 mRNA (see Fig . 3, below) .
Immunoprecipitationofa, Subunit,
A polyclonal anti-peptide serum was prepared in the laboratory of Dr. J .
McDonald (Washington University, St . Louis) using the synthetic peptide
CRIQPSETERLTDDY. This peptide contains the COOH-terminal 14
amino acidspredicted for a putativechicken CSAT antigen band2 sequence
(28), and the COOH-terminal 12 amino acids are identical to those
predicted for human 013 (see Fig. 4, below) . The rabbit anti-013 000H-
terminal peptide serum and the anti-013 mAb J143 (16) were used to immu-
noprecipitate 013 protein from detergent lysate ofLOX cells (a melanoma
line), and these were analyzed by SDS-PAGE as previously described (24) .
DNA Sequencing
The DNA sequences were determined by the dideoxy nucleotide chain-
termination method of Sanger et al . (41), using adenosine [35S]5'-[a-thio]-
triphosphate . To facilitate complete sequencing of both cDNA strands, a
series of overlapping deletion clones was made in both directions as de-
scribed (25) by using the Erase-a-base system (Promega Biotec) . Alter-
natively, synthetic oligonucleotides (N20 bases) corresponding to known
013 sequence regions were used as sequencing primers . Clones 3.24 and
3.285, and 5'-1 kb of clone 3.410 were sequenced in both directions .
1 . Abbreviations used in this paper : PBST, PBS plus 0.2% Tween-20.
258Figure 2 . Immunoprecipitation of the a3 subunit . Immunoprecipi-
tation was carried out using extract from the surface 1z5I-radiola-
beled melanoma cell line LOX. After immunodepletionof labeled
material reacting with negative control antibody (lanes a-c), the
anti-a3 MAb J143 (lanes d-f), or rabbit anti-a3 peptide serum
(lanes g-i), the remaining LOXextractwasthen subjected to a sec-
ond round ofimmunoprecipitation using J143 (lanes a, d, g), rabbit
anti-a3 peptide (lanes b, e, h), or a negative control antibody
(lanes c, f, i) .
Construction of the a,cDNA Expression Vectorand
T"ansfection ofCHO Cells
TheBamHI (inthe vectorpolycloning site)/NdeI fragment (0.9 kb) ofclone
3.410 and the NdeI/EcoRl fragment (1.66 kb) of clone 3.285 were ligated
to the BamHI/EcoRI fragment (3 kb) of Bluescript KSII+ vector. The
resulting pBSKSII+ (a3; 1-2465) was digested with HindIII and Sall and
the large Sall (in the vector polycloning site)/HindlH fragment (5.46 kb)
was ligated with HindIII/Sall fragment (1.08 kb) of cDNA clone 3.520 (Sall
site derives from a linker used for ligation ofcDNA to phage vector) . The
Xhol site in the resulting pBSKSII+ (as ; 1-3470) was converted to XbaI
site by digesting with Xhol, filling in reaction with Klenow enzyme, and
insertion of XbaI linker. The resulting pBSKSII+(a3;X/X) was digested
with Xbal and the Xbal fragment (3.47 kb) containing a3 coding region
was ligated to the XbaI-digested, calf intestinal alkaline phosphatase-
treatedCDM8 vector. 10 hg ofthe purified plasmid was transfected to 107
CHO cells by electrophoration (8) . 72 h after transfection, cells were har-
vested with 3.5 mM EDTA in 0.14MNaCl and 10mM sodium phosphate
(pH7.4), incubated withprimary mousemonoclonal antibody andthen with
FITC-labeled goat anti-mouse IgG antibody, and subjected to a fluores-




An antiserum preparation made against purified placental
a3 protein was enriched for a3 specific antibodies using an
a3#1 Sepharose affinity column . The purified anti-a3 anti-
body preparation strongly recognized a band (M r 150,000)
2 . FACS is a registered trademark of Becton Dickinson and Company .





















Figure 3 . Overlapping a3cDNA fragments . cDNA clone 3.24 was
obtained from an endothelial cell Xgtll cDNA library, clones 3.122
and3.285 from that ofHepG2hepatocarcinoma cell line, and3.410
and 3.520 from another endothelial cellcDNA library . Sites of re-
striction enzymes used for reconstruction of a3 cDNA coding re-
gion are shown . B, BamHI; E, EcoRl ; H, HindIII ; N, NdeI .
from crude cellular extracts and purified a30 1 preparation
with very little background (not shown) . We then used the
purified antibody for immunoselection of a3 cDNA clones
from a Xgtll cDNA library from endothelial cells whichare
known to express substantial amount of a3 protein (2) .
From a few representative isolates, cDNA clones 3.22 and
3.24 were found to cross-hybridizeto each otherby Southern
blotting . Then a-galactosidase fusion proteins (Fig . 1, a-e)
were prepared from several clones, and of these, the fusion
proteins from clones 3.22 and 3.24 were recognized by an-
tiserum enriched for anti-as antibodies (Fig . 1 B, lanes a,
b) . Two other fusion proteins (lanes c, d) andE. coli strain
Y1089 control protein (lane e) were not recognized by anti-
a3 antibodies . In a reciprocal experiment, clone 3.22 fusion
proteinwascoupledto Sepharose and then used to enrich for
anti-fusion protein antibodies . This antibody preparation
(derived from the original crudeantiserum) wasimmunolog-
ically reactive with both the fusion protein itself and with
purified a3 (Fig. 1 C) . The cDNA clone 3.24 was sub-
cloned into a plasmid and sequenced, and found to have an
amino acid sequence (about 100 residues) similar to the
C0011-terminal regions of other knownintegrin a subunits .
Immunological Evidencefor the Identity
of the a,Clone
To further assess the identity of the putative a3 cDNA, rab-
bit antiserum against a synthetic peptide containing the
COOH-terminal 12aminoacids from thepredicteda3amino
acid sequence was used to immunoprecipitate a 150,000-M,
protein from radiolabeled LOX cells (Fig . 2, lane b) which
comigrates with authentica3 immunoprecipitated using the
mAb J143 (lane a) . In addition, prior immunodepletion of
the LOX cell extract with either themAb J143 (lanes df),
or with anti-peptide rabbit serum (lanes g-i), almost com-
pletelyeliminated subsequent immunoprecipitation by either
J143 (lanes d, g) or by the anti-peptide serum (lanes e, h) .
Isolation ofClones Corresponding to
Full-Length a, cDNA
When a human Hep G2 XgtlI cDNA library was screened
using the cDNA clone 3.24 as a probe, additional clones
(3.285 and 3.122) were selected which extended 1.8 kb be-
yond the 5' end of clone 3.24 . Finally, a clone (3.410) was
isolated from another endothelial Xgtll cDNA library thataggtgaacaggtcctcacgcccagctccgccccctcacgcgctctcgccgggaccccgct 60
tccgctggcagcc t®ggccccggccccagccgcgcgccccgcgccccacgcctgatgct 120
M G P G P S R A P R A P R L M L
ctgtgcgctcgccttgatggtggcggccggcggctgcgtcgtctccgccttcaacctgga 180




























































































T A H K D D C E R M N* I T V K N D P G H
tcacattattgaggacatgtggcttggagtgactgtggccagccagggccctgcaggcag 480
117 H I I E D M W L G V T V A S Q G P A G R
agttctggtctgtgcccaccgctacacccaggtgctgtggtcagggtcagaagaccagcg 540
137 V L V C A H R Y T Q V L W S G S E D Q R
gcgcatggtgggcaagtgctacgtgcgaggcaatgacctagagctggactccagtgatga 600
157 R M V G K C Y V R G N D L E L D S S D D
ctggcagacctaccacaacgagatgtgcaatagcaacacagactacctggagacgggcat 660
177 W Q T Y H N E M C N S N T D Y L E T G M
gtgccagctgggcaccagcggtggcttcacccagaacactgtgtacttcggcgcccccgg 720
197 C Q L G T S G G F T Q N T V Y F G A P G
tgcctacaactggaaaggaaacagctacatgattcagcgcaaggagtgggacttatctga 780
217 A Y N W K G N S Y M I Q R K E W D L S E
gtatagttacaaggacccagaggaccaaggaaacctctatattgggtacacgatgcaggt 840
237 Y S Y K D P E D Q G N L Y I G Y T M Q V
aggcagcttcatcctgcaccccaaaaacatcaccattgtgacaggtgccccacggcaccg 900
257 G S F I L H P K N I T I V T G A P R H R
acatatgggcgcggtgttcttgctgagccaggaggcaggcggagacctgcggaggaggca 960
277 H M G A V F L L S Q E A G G D L R R R Q
ggtgctggagggctcgcaggtgggcgcctattttggcagcgcaattgccctggcaacct 1020
297 V L E G S Q V G A Y F G S A I A L A D L
aacaat at ct ca acctcctggtgggcgccccctactacttcgagaggaaaga 1080
317 N N D G W Q D L L V G A P Y Y F E R K E
ggaagtagggggtgccatctatgtcttcatgaaccaggcgggaacctccttccctgctca 1140
337 E V G G A I Y V F M N Q A G T S F P A H
cccctcactccttcttcatggccccagtggctctgcctttggtttatctgtggccagcat 1200
357 P S L L L H G P S G S A F G L S V A S I





































397 G K V Y I Y H S S S K G L L R Q P Q Q V
aatccatggagagaagctgggactgcctgggttggccaccttcggctattccctcagtgg 1380
417 I H G E K L G L P G L A T F G Y S L S G
gcagat at t at a aacttctaccca accttctagtgggaagcctgtcagacca 1440
437 Q M D V D E N F Y P D L L V G S L S D H
cattgtgctgctgcgggcccggccagtcatcaacatcgtccacaagaccttggtgcccag 1500
457 I V L L R A R P V I N I V H K T L V P R
gccagctgtgctggaccctgcactttgcacggccacctcttgtgtgcaagtggagctgtg 1560




F A Y N* Q S A G N P N Y R R N* I T L A Y
Figure 4. Complete nucleotide sequence of a3 subunit cDNA and deduced amino acid sequence. The initiation codon, stop codon, and
potential metal binding domains are boxed. The NH2-terminal amino acid sequence, putative transmembrane domain, and polyadenyla-
tion signal (AATAAA) are underlined. N*, a potential N-glycosylation site. These sequence data are available from EMBL/GenBank/DDBJ
under accession number M59911.
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260cactctggaggctgacagggaccgccggccgccccggctccgctttgccggcagtgagtc 1680
517 T L E A D R D R R P P R L R F A G S E S
cgctgtcttccacggcttcttctccatgcccgagatgcgctgccagaagctggagctgct 1740




L M D N L R D K L R P I I I S M N* Y S L
acctttgcggatgcccgatcgcccccggctggggctgcggtccctggacgcctacccgat 1860




L N Q A Q A L E N* H T E V Q F Q K E C G
gcctgacaacaagtgtgagagcaacttgcagatgcgggcagccttcgtgtcagagcagca 1980
617 P D N K C E S N L Q M R A A F V S E Q Q
gcagaagctgagcaggctccagtacagcagagacgtccggaaattgctcctgagcatcaa 2040
637 Q K L S R L Q Y S R D V R K L L L S I N*
cgtgacgaacacccggacctcggagcgctccggggaggacgcccacgaggcgctgctcac 2100
657 V T N T R T S E R S G E D A H E A L L T
cctggtggtgcctcccgccctgctgctgtcctcagtgcgcccccccggggcctgccaagc 2160




N* E T I F C E L G N P F K R N Q R M E L
gctcatcgcctttgaggtcatcggggtgaccctgcacacaagggaccttcaggtgcagct 2280
717 L I A F E V I G V T L H T R D L Q V Q L
gcagctctccacgtcgagtcaccaggacaacctgtggcccatgatcctcactctgctggt 2340
737 Q L S T S S H Q D N L W P M I L T L L V
ggactatacactccagacctcgcttagcatggtaaatcaccggctacaaagcttctttgg 2400
757 D Y T L Q T S L S M V N H R L Q S F F G
ggggacagtgatgggtgagtctggcatgaaaactgtggaggatgtaggaagccccctcaa 2460
777 G T V M G E S G M K T V E D V G S P L K
gtatgaattccaggtgggcccaatgggggaggggctggtgggcctggggaccctggtcct 2520
797 Y E F Q V G P M G E G L V G L G T L V L
aggtctggagtggccctacgaagtcagcaatggcaagtggctgctgtatcccacggagat 2580








N* L T L S D P G D R P S S P Q R R R R Q
gctggatccagggggaggccagggccccccacctgtcactctggctgctgccaaaaaagc 2760
877 L D P G G G Q G P P P V T L A A A K K A
caagtctgagactgtgctgacctgtgccacagggcgtgcccactgtgtgtggctagagtg 2820




P I P D A P V V T N* V T V K A R V W N* S
caccttcatcgaggattacagagactttgaccgagtccgggtaaatggctgggctaccct 2940




F L R T S I P T I N M E N* K T T W F S V
ggacattgactcggagctggtggaggagctgccggccgaaatcgagctgtggctggtgct 3060
977 D I D S E L V E E L P A E I E L W L V L
ggtggccgtgggtgcagggctgctgctgctggggctgatcatcctcctgctgtggaagtg 3120
997 V A V G A G L L L L G L I I L L L W K C
cggcttcttcaagcgagcccgcactcgcgccctgtatgaagctaagaggcagaaggcgga 3180
1017 G F F K R A R T R A L Y E A K R Q K A E
gatgaagagccagccgtcagagacagagaggctgaccgacgactac q~agggggcagccc 3240
1037 M K S Q P S E T E R L T D D Y
Figure 4.



























encoded an N112-terminal sequence (FNLDTRFLVVKEAG)
which exactly corresponds to the N112-terminal sequence of
the mature a3 subunit (48). The clone 3.410 also contained a
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Fluorescence Intensity
Figure 5. Transient expression ofhuman a3 subunit in CHO cells.
Human a3 subunit cDNA expression plasmid was constructed as
described in Materials and Methods. 10 jig of the plasmid was
transfected into 107 CHO cells by electroporation. After 72 h in
medium with 10% FCS, cells were harvested, stained with mAb
J143 followed by FIX-labeled goat anti-mouse IgG antibody and
subjected to FACS analysis. Also a FACS profile of a typical nega-
tive control is shown (e.g., cells transfected with CDM-8 vector
only and stained with mAb J143).
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From the various overlapping cDNA clones (Fig. 3), the
complete sequence for the a3 coding region, and some of
the 3' and 5' untranslated regions was obtained (Fig. 4) . The
3' untranslated region contained the poly A addition sig-
nal AATAAA. Translation of the a3 cDNA yielded 1,051
amino acids including a signal sequence (32 residues). The
predicted mass of mature a3 subunit peptide is calculated as
113,505. The a3 subunit sequence has 13 potential N-gly-
cosylation sites (Asn-X-Ser/Thr, where X is not Pro) . If
carbohydrate chains with an average molecular weight of
2,500 are assumed to attach to all 13 putative glycosylation
sites, the total molecular weight of the mature 013 subunit
would be 146,000. This value is consistent with the estimated
size from the relative mobility on SDS-PAGE (M, 145,000-
150,000) . The a3 subunit has been reported to be cleaved to
heavy and light chains upon reduction (M, 110,000 and
30,000, respectively). Consistent with this, there are two po-
tential cleavage sites (QRRRR) and (AKKAK), character-
ized by dibasic residues, which are located in the same region
(residues 839-864) as cleavage sitespredicted for the integrin
015, CG, am, Subunits. As noted for other published integrin a
subunits (3-5, 9, 10, 15, 29, 32, 38, 39, 45-47, 51), the N112-
terminal portion of the a3 sequence contains seven similar
repeating units (I, residue 18-60; II, 99-131; III, 165-193;
IV, 295-329; V, 352-390; VI, 415-447; VII, 475-512),
which are each 28-42 aminoacids in length, and are 20-30
similar. Repeating domains V, VI, and VII each contain apu-
tative divalent cationbinding region, of the general structure
of DX(D/N)X(D/N)GXXD. This sequence is foundamonga
variety of Cat+ and Mgt+ binding proteins including integrinsFigure 6 . RNA hybridization
analysis . From the leukemic
cell lines MOLT-4 and HSB
and from the fibroblast cell
line MRC, total RNA (5 ug
per, lane) was electrophoreti-
cally separatedon 1% agarose-
formaldehyde gels, transferred
to nylon membrane (Nytran;
Schleicher & Schuell, Inc.,
Keene, NH), and then probed
with 32P-labeled a3 cDNA
clothe3.24 . Ina control experi-
ment (below), the same RNA
samples were probed with ac-
tin ODNA .
(3-5, 9, 10, 15, 29, 32, 38, 39, 45, 415, 50, 51, 53) . Whereas
several other integrin a subunits contain a 180-200 amino
acid insert (called I domain) between repeating domains H
and III (4, 9, 10, 29, 32, 39, 47), &3 subunit has no such
domain .
Transient Expression ofHuman X143 Subunit
in CHO Cells
The a3 expression plasmid was constructed as described in
Materials and Methods and was tr"fected into CHO cells
by electroporation . After 72 h, the human a3 subunit was
expressed on the surface of20% of
the
transfected cells as
detected by a3-specific mAb J143 (Rig. 5), further indicat-
ing that the a3 cDNA is authentic. IJ,ecause integrin a sub-
unit expression at the cell surface is known to require an as-
sociated S subunit, and because human a3 has previously
been found to associate with rodent 0, (30), it is presumed
that transfected a3 in this experiment is associated with
hamster a, at the cell surface.
Northern BlottingAnalysis
Upon probing of total RNA with cY~ clone 3.24, a single
band (5 kb) was obtained from the fibroblast cell line MRC
(Fig . 6, lane c) . In contrast, only a fait band was seen from
the leukemic T cell lines Molt-4 and HSB. These results are
consistent with the relative levels of surface expression of



















Figure 7 . Alignment of human a3, hamster Gapb3 and chicken
CSAT antigen band 2 sequences . CSAT band 2 (43) partial amino
acid sequence (170 residues) was aligned with the corresponding
part of the human a3 and hamster Gap b3 (52) sequences by using
the GAP program of UWGCG (12) .
a 3 protein on these cells (23) . Hybridization of the same
blot with cDNA probe for the human actin gene gave com-
parable signals in all lanes.
Discussion
This paper describes the cloning, sequencing, and expres-
sion in eukaryotic cells ofcDNA for the human integrin a3
subunit of the VLA-3 (a30,) heterodimer . The a3 cDNA is
authentic because (a) the NH2-terminal amino acid se-
quence deduced from the nucleotide sequence is identical
to that from purified a3 peptides (48), (b) a3 fusion pro-
teins were immunologically cross-reactive with purified a 3
protein, (c) rabbit antiserum against a predicted a3 COOH-
terminal synthetic peptide recognized the a3 subunit, and
(d) the anti a3 mAb J143 recognized CHO cells transfected
with a3 cDNA in CDM8 vector.
This paper shows that hamster galactoprotein b3 (Gapb3)
is 89% homologous to the human a 3 subunit with uniform
similarity throughout the two molecules . There is high con-
servation (100%) of the 40 COOH-terminal residues (52) .
Also a partial amino acid sequence of chicken CSAT band
2 protein (28) is 70% similar to the corresponding region
(COOH-terminal 170 residues) of the human a3 sequence
(Fig . 7) . Thus, it is proposed that Gapb3 and CSAT antigen
band 2 are homologues of the human a3 subunit. In this re-
gard, CSAT protein and a3at were previously shown to be
immunologically cross-reactive (48), and CSAT band 2
cDNA cross-hybridized with a3 cDNA in Southern blots
(not shown) .
Whereas Tsuji et al . (1990) (52) showed the homology of
Gapb3 to human a 3 subunit from only a very limited NH2-
terminal amino acid sequence comparison (14 residues), this
work provides compelling evidence of the homology of hu-
man and hamster protein .
Alignment of a3 with at, 012, a<, as, a6, a. shows that the
essential features of integrin a subunits are conserved in the
a 3 subunit (Fig. 8) . From the alignment of these a sub-
units, along with the other integrin a subunits am a,., aM ,
ax, PS2a, an a subunit similarity tree was constructed
(Fig . 9) . Overall, the a 3 amino acid sequence was 25-37%
similar to the other integrin a subunits that are cleaved into
disulfide-linked fragments, and less similar to those a
subunits that have I domains (15-20%, excluding the I do-
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Figure 8. Alignment of a3 pro-
tein sequence with other integrin
a subunits that associatewith the
0, subunit. Aminoacid sequences
for human a3, a2, (46), as (50),
as (3, 15), a6 (51), a~ (45), and
rat a, (29) are aligned, and resi-
dues conserved in at least six of
the sequences are marked with
"*," and conserved cysteines are
marked with "1" Regions corre-
sponding to the seven repeating
domains are underlined, and re-
gions corresponding to the I-do-
mains in a, and a2 (201 and 190
amino acids, respectively) have
been omitted. Initial alignments
were carried out using the com-
puterprogramofSmithandSmith
(42), andthen minor adjustments
were made by eye to improve the
alignment, with emphasison main-
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Subunits
Figure 9 Integrin a subunit similarity tree. Amino acid sequences
for the human subunits a (45), a5 (3, 15), a,tb (38), a3, as (51),
a4 (46), aZ (47), a,, (32), aM (4, 9), ax (10), the Drosophila PS2a
(5), hamster Gapb3 (52), rat a,r (29), and mouse amm (39) were
aligned using the program of Smith and Smith (42), and similarity
scores were generated, andthen averaged similarity scores were used
to construct the similarity tree.
(37%) to the a6 subunit is much higher than the average
similarity (-25 %) between a3 and other integrin a sub-
units, suggesting that a3 is evolutionarily closer to ae than
the others. This pair ofa subunits also has an unusually high
degree of similarity within their short cytoplasmic domains
(13/30 = 43% identity). No other pair of a subunits is that
similar in their cytoplasmic domains. For example, even
though cam and ax are 60% similar overall, and cav and a5
are 43 % similar overall, these pairs are only 25 and 24%
similar, respectively, in their cytoplasmic domains. Re-
cently, both COO, and a6s1 have been shown to recognize
the E8 fragment of laminin, which is located COOH-termi-
nal of the laminin cross (17, 20, 44) . It is possible, based on
the evolutionary similarity of the two subunits, that they
recognize the same site of laminin by a similar mechanism.
The present human a3 subunit cDNA clone will be useful
in future studies (a) to directly evaluate the role of a3a1 in
migration, invasion and metastasis and (b) to study the
mechanism of recognition of multiple ligands by a3131. For
example, it will beparticularly interesting to examine the be-
havior in vitro and in vivo of the transfected CHO cells or
other cells overproducing human a3a, .
We wish to thank David Mandelman for help in transfection and FACS
analysis.
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